| Literature DB >> 30111527 |
Miel Ap Vugts1, Margot Cw Joosen1, Agali Mert2, Aglaia Me Zedlitz3, Hubertus Jm Vrijhoef4,5,6.
Abstract
BACKGROUND: Current evidence for the effectiveness of specialist multidisciplinary programs for burdensome chronic pain and functional somatic syndromes drives the effort to improve approaches, strategies, and delivery modes. It remains unknown to what extent and in what respect serious gaming during the regular outpatient rehabilitation can contribute to health outcomes.Entities:
Keywords: behavioral intervention; chronic pain; musculoskeletal disease; rehabilitation; serious games; therapy
Mesh:
Year: 2018 PMID: 30111527 PMCID: PMC6115601 DOI: 10.2196/jmir.9739
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Overview of program components offered during the first and second halves of the regular multidisciplinary rehabilitation program.
| Components offered | Weeks 1-8 | Weeks 9-16 |
| Physical therapy | Graded activity (group) Exercise therapy Physiotherapya Education (lifestyle, pain physiology) | Graded activity (group) Exercise therapy |
| Psychotherapy approaches | Coping with stress Extinction of fear-avoidance beliefsa Cognitive restructuringa Eye movement desensitizationa Mentalization techniquesa | Coping with stress Cognitive restructuring |
| Activating and counseling in social role participation | Work and health (education and counseling) Social skills | |
| Mindfulness interventions | Rationale Psychological well-being assessment Mental training Additional 2-day course (mental training skills) | Mental training |
aAllocation depended on examination results.
Primary and secondary outcome measures.
| Variables | Survey information | Timea | |
| Pain intensity | Current pain intensity Numerical Rating Scale 0-100 [ | t0, t1, t2 | |
| Fatigue | Checklist Individual Strength [ | t0, t1, t2 | |
| Psychological distress | Symptom Checklist [ | t0, t1, t2 | |
| Pain coping and cognition | Pain Coping & Cognitions List; catastrophizing subscale [ | t0, t1, t2 | |
| Global impression of change, general health, and functioning | How do you assess your health, compared with the situation at the start of your treatment? (−2, much, or −1, slightly declined; 0, neither declined nor improved; 1, slightly, or 2, much improved) What do you think of your current health in general? (0, bad-100, excellent) Please indicate how satisfied you are generally taken with your current level of functioning. (0, not at all satisfied-100, very satisfied) Please indicate the distance from your “old” level of functioning before the onset of the complaint. (0, very far removed-100, not at all removed) | t1, t2 | |
| Treatment satisfaction | Would you recommend this treatment center to other rehabilitation patients? (1, certainly not; 2, probably not; 3, probably yes; 4, certainly yes); item from the consumer quality (CQ) index [ Which grade would you give to the rehabilitation center? (0-10; CQ-index) Did the treatment meet your expectations? (1, not at all; 2, mostly not; 3, mostly; 4, completely) | t2 | |
at0=baseline; t1=intermediate (after 8 weeks of treatment); t2=posttreatment (after 16 weeks of treatment).
Figure 1The CONSORT flowchart of participants.
Participants’ baseline characteristics.
| Variable | Intervention group (n=159) | Control group (n=116) | Full sample (N=275) | Group difference | ||
| Student | ||||||
| Age (years), mean (SD) | 44.2 (11.55) | 44.9 (11.42) | 44.5 (11.48) | .60 | ||
| Female gender, n (%) | 104 (66.7) | 88 (73.9) | 192 (69.8) | χ21=1.7 | .19 | |
| Socioeconomic status scoreb, mean (SD) | −.05 (0.95) | −.36 (1.28) | −.18 (1.12) | .03 | ||
| Returned to work (at intermediate) | 16 (10.3) | 24 (20.2) | 40 (14.5) | χ21=5.4 | .02 | |
| χ23=2.1 | .56 | |||||
| Primary school | 1 (1.3) | 0 (0.0) | 1 (0.8) | |||
| Lower secondary education | 21 (27.3) | 12 (21.8) | 33 (25.0) | |||
| Higher secondary education | 28 (36.4) | 19 (34.5) | 47 (35.6) | |||
| Tertiary education | 28 (36.4) | 23 (41.8) | 51 (38.6) | |||
| χ23=1.6 | .67 | |||||
| Full-time employed | 24 (15.1) | 18 (15.5) | 42 (15.3) | |||
| Fully absent | 55 (34.6) | 48 (41.4) | 103 (7.5) | |||
| Partially absent | 39 (24.5) | 31 (26.7) | 70 (25.5) | |||
| Unemployed | 38 (24.4) | 22 (18.5) | 60 (21.8) | |||
| Neck or head | 77 (49.4) | 61 (51.3) | 138 (50.2) | χ21=0.1 | .76 | |
| (Low) back | 92 (59.0) | 92 (77.3) | 184 (66.9) | χ21=10.3 | .001 | |
| Upper extremities | 57 (36.5) | 44 (37.0) | 101 (36.7) | χ21=0.0 | .94 | |
| Lower extremities | 59 (37.8) | 57 (47.9) | 116 (42.2) | χ21=2.8 | .09 | |
| χ23=1.9 | .60 | |||||
| 3-6 months | 13 (8.4) | 10 (8.4) | 23 (8.4) | |||
| 6-12 months | 35 (22.6) | 20 (16.8) | 55 (20.1) | |||
| 1-2 years | 36 (23.2) | 26 (21.8) | 62 (22.6) | |||
| >2 years | 71 (45.8) | 63 (52.9) | 134 (48.9) | |||
| χ22=0.1 | .95 | |||||
| Deteriorating | 100 (4.1) | 76 (63.9) | 176 (4.0) | |||
| Improving | 23 (14.7) | 19 (16.0) | 42 (15.3) | |||
| Cardiology | 19 (12.2) | 25 (21.0) | 44 (16.0) | χ21=4.0 | .048 | |
| Neurology | 16 (10.3) | 0 (0.0) | 16 (5.8) | χ21=13.0 | <.001 | |
| Endocrinology | 14 (9.0) | 10 (8.4) | 24 (8.7) | χ21=0.0 | .87 | |
| Pulmonology | 24 (15.4) | 19 (16.0) | 43 (15.6) | χ21=0.0 | .90 | |
| χ24=1.7 | .79 | |||||
| Never | 54 (36.2) | 44 (37.3) | 98 (36.7) | |||
| 1-2 times | 49 (32.9) | 37 (31.4) | 86 (32.2) | |||
| 3 times or more | 46 (30.9) | 37 (31.3) | 83 (31.1) | |||
| Body mass index (kg/m2), mean (SD) | 27.0, 5.16 | 27.1, 5.13 | 27.1, 5.13 | .86 | ||
| (Very) low oxygen absorption capacity (Åstrand class)d, n (%) | 44 (38.3) | 36 (42.3) | 80 (40.1) | χ21=3.0 | .81 | |
| Symptom recurrence (yes), n (%) | 93 (59.6) | 73 (61.3) | 166 (60.4) | χ21=0.1 | .77 | |
| Previous specialized medical care received (yes), n (%) | 101 (64.7) | 85 (71.4) | 186 (67.6) | χ21=1.4 | .24 | |
| Treated elsewhere (baseline), n (%) | 81 (52.3) | 64 (53.8) | 145 (52.9) | χ21=0.1 | .80 | |
| Medication intake, n (%) | 104 (66.7) | 93 (78.2) | 197 (71.6) | χ21=4.4 | .04 | |
aIf Levene’s test for equality of variances was significant, equal variances were not assumed.
bThe socioeconomic status (SES) index by neighborhood is derived from a number of characteristics of the people living there: their education, income, and position in the labor market. The higher the index, the higher the SES. Nationally, the mean is 0, SD is 1.09, and the minimal and maximal scores are −6.75 and 3.06, respectively.
cHighest education data were incomplete because it was not administered for a part of the course of the natural experiment; missing values (N=143) were group independent.
dPhysical condition: age- and weight-corrected oxygen absorption capacity measured using the submaximal Åstrand performance test. Missing values are because of the exclusion of observations under 120 beats per minute or testing contraindications (ie, high blood pressure).
Primary outcome scores.
| Outcome; measure and timea | Intervention group | Control group | |||
| Number of observations | Mean (SD) | Number of observations | Mean (SD) | ||
| t0 | 156 | 56.60 (32.27) | 119 | 58.71 (30.92) | |
| t1 | 156 | 35.79 (25.80) | 119 | 35.03 (26.31) | |
| t2 | 150 | 26.08 (24.07) | 118 | 29.81 (25.56) | |
| t0 | 154 | 110.97 (18.63) | 118 | 108.05 (15.88) | |
| t1 | 154 | 84.05 (26.51) | 118 | 83.42 (24.57) | |
| t2 | 147 | 60.68 (27.04) | 116 | 65.62 (26.07) | |
| t0 | 126 | 3.54 (0.94) | 97 | 3.46 (0.86) | |
| t1 | 126 | 2.68 (0.86) | 97 | 2.60 (0.93) | |
| t2 | 121 | 2.10 (0.90) | 95 | 2.05 (0.88) | |
| t0 | 156 | 195.25 (50.55) | 119 | 193.21 (49.40) | |
| t1 | 156 | 161.93 (43.21) | 119 | 151.18 (35.92) | |
| t2 | 149 | 120.45 (32.96) | 117 | 118.26 (28.90) | |
at0=measurement; t1=intermediate (after 8 weeks of treatment); t2=posttreatment (after 16 weeks of treatment).
bNorm information for the CIS: average for healthy controls, mean=41.5, SD, 19.8; average of a norm group of patients with chronic fatigue syndrome, mean=113.3, SD, 14.6.
cSome data are missing by the design of routine outcome monitoring; PCCL scores are absent for very low pain intensity scores.
dThe baseline mean is high compared with a norm group of patients with chronic pain.
Figure 2Patterns of primary outcome change during rehabilitation between the groups.
Figure 3Within-group proportions for reliable improvement or decline in one or more of the 4 primary outcomes between the groups.
Univariate linear mixed modeling results.
| Subscale used and timea | Intervention group | Control group | Effect | Unstandardized | ||||
| Number of | Mean (SD) | Number of | Mean (SD) | |||||
| t0 | 156 | 40.49 (12.22) | 119 | 39.87 (12.69) | t0-1c | −8.50 (0.92) | <.001 | |
| t1-2 | −7.20 (0.71) | <.001 | ||||||
| t1 | 156 | 31.99 (11.31) | 119 | 28.89 (8.94) | t0-1 × Xd | 2.52 (1.40) | .07 | |
| t2 | 149 | 24.85 (8.64) | 117 | 24.50 (7.95) | t1-2 × X | −2.75 (1.07) | .01 | |
| t0 | 156 | 24.63 (6.68) | 119 | 23.96 (7.15) | t0-1 | −4.5 (0.48) | <.001 | |
| t1-2 | −4.0 (0.43) | <.001 | ||||||
| t1 | 156 | 20.1 (6.05) | 119 | 18.62 (5.55) | t0-1 × X | .82 (0.76) | .27 | |
| t2 | 149 | 16.11 (5.57) | 117 | 15.97 (5.41) | t1-2 × X | −1.36 (0.65) | .04 | |
| t0 | 154 | 26.69 (7.62) | 118 | 24.71 (7.34) | t0-1 | −4.84 (0.70) | <.001 | |
| t1-2 | −5.96 (0.55) | <.001 | ||||||
| t1 | 154 | 21.85 (7.80) | 118 | 21.03 (7.20) | t0-1 × X | −1.25 (1.06) | .24 | |
| t2 | 147 | 15.84 (7.88) | 116 | 16.27, (7.24) | t1-2 × X | −1.17 (0.83) | .16 | |
at0=measurement; t1=intermediate (after 8 weeks of treatment); t2=posttreatment (after 16 weeks of treatment).
bSidak-Holm-corrected alpha criterion levels were applied to the 3 primary outcomes, being .02 for the lowest P value, .03 for the second highest P value, and .05 for the highest P value.
ct1 parameters in this table are multiplied by −1 because t1 (index=3) was the reference category.
eX: intervention group.
Secondary outcomes by group and time (t1=intermediate [after 8 weeks of treatment]; t2=posttreatment [after 16 weeks of treatment]).
| Outcome | Intervention group | Control group | ∆ Group (by time)a | |||||||
| t1 (n=156) | t2 (n=150) | t1 (n=119) | t2 (n=118) | Student | ||||||
| .77 | ||||||||||
| Much deteriorated | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1 (0.1) | ||||||
| Slightly deteriorated | 5 (3.2) | 4 (2.8) | 2 (1.7) | 5 (4.3) | ||||||
| Stable | 16 (10.3) | 10 (6.9) | 25 (21.0) | 6 (5.2) | ||||||
| Slightly improved | 97 (62.2) | 46 (31.7) | 63 (52.9) | 41 (35.3) | ||||||
| Much improved | 37 (13.5) | 85 (58.6) | 28 (23.5) | 63 (54.3) | ||||||
| .25b | ||||||||||
| General health | 55.45 (24.18) | 71.23 (22.57) | 57.97 (23.17) | 71.90 (20.39) | ||||||
| Functioning “level” | 46.05 (25.81) | 70.19 (25.22) | 50.02 (25.66) | 69.78 (24.53) | ||||||
| Functioning “distance” | 40.12 (25.34) | 55.47 (32.10) | 42.04 (27.65) | 52.85 (31.37) | ||||||
| Rating program | N/Ac | 8.33 (1.20) | N/A | 8.06 (1.46) | .10 | |||||
| .09 | ||||||||||
| Certainly not | N/A | 0 (0.0) | N/A | 0 (0.0) | ||||||
| Probably not | N/A | 4 (2.7) | N/A | 9 (7.6) | ||||||
| Probably yes | N/A | 40 (26.7) | N/A | 37 (31.4) | ||||||
| Certainly yes | N/A | 106 (70.7) | N/A | 72 (61.0) | ||||||
| .20 | ||||||||||
| Not at all | N/A | 0 (0.0) | N/A | 3 (2.5) | ||||||
| Mostly not | N/A | 14 (9.3) | N/A | 12 (10.2) | ||||||
| Mostly | N/A | 84 (56.0) | N/A | 58 (49.2) | ||||||
| Completely | N/A | 52 (34.7) | N/A | 45 (16.8) | ||||||
aIf data were available at intermediate and posttreatment, group differences were assessed in change from intermediate to posttreatment.
bGroup differences were tested in a change of the average scores over the sums of three items (that together formed an internally consistent scale); similar results were obtained if MIXED or repeated measures analysis of variance was used.
cN/A: not applicable.